头颈部癌软组织放射性坏死诊断挑战
一例53岁舌根鳞癌患者接受根治性放化疗后,6周FDG PET/CT示原发灶部分代谢缓解伴软组织积气提示放射性坏死、颈部完全缓解;9周增强CT示溃疡加重但无强化,活检见微小癌灶伴治疗效应;12周PET/CT示原发灶摄取增高判为进展,但挽救手术未见存活肿瘤。无强化溃疡预示纯放射性坏死无存活肿瘤,增强CT或可指导疑难病例治疗选择。
要点
- 放化疗后原发灶软组织积气可提示放射性坏死。
- 无强化溃疡预示纯放射性坏死、无存活肿瘤。
- PET/CT摄取增高不一定代表存活肿瘤,需结合增强CT。
核心结论
- 无强化溃疡预示纯放射性坏死且无存活肿瘤,增强CT可能指导疑难病例的治疗选择。
研究设计与样本
- 一例53岁男性舌根鳞状细胞癌(T4aN2cM0)接受根治性放化疗后的病例报告,含6周FDG PET/CT、9周增强CT与活检、12周PET/CT及挽救手术病理。
主要发现
- 6周FDG PET/CT示原发灶部分代谢缓解伴软组织积气提示放射性坏死,颈部完全缓解。
- 9周增强CT示溃疡加重但无强化,活检示微小癌灶伴治疗效应。
- 12周PET/CT示原发灶摄取增高判为疾病进展,但挽救手术未发现存活肿瘤。
临床怎么用
- 对放化疗后疑难病例,增强CT显示无强化溃疡可能提示纯放射性坏死、无存活肿瘤,或可据此指导治疗选择。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 53-year-old man with T4aN2cM0 tongue base squamous cell carcinoma received definitive chemoradiation. FDG PET/CT at 6 weeks showed partial metabolic response with soft tissue air indicating radiation necrosis at primary site and complete response in the neck. At 9 weeks, contrasted CT showed worsening but nonenhancing ulceration, area biopsied demonstrating a minute carcinoma focus with treatment effect. At 12 weeks, PET/CT showed increased primary site uptake interpreted as disease progression; however, no viable tumor was found at salvage surgery. Because nonenhancing ulceration predicts pure radiation necrosis with no viable tumor, contrasted CT may guide treatment selection in challenging cases.
引用
- Pucar D, Groves MW, Biddinger P, et al. Head and Neck Cancer Soft Tissue Radiation Necrosis-Diagnostic Challenge. Clin Nucl Med. 2019. PMID: 30371592. doi:10.1097/RLU.0000000000002356
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。